Patent · US Active

Microorganisms engineered to reduce hyperphenylalaninemia

US11766463B2 · kind B2 · utility

2Cited by

13References

8Claims

0Family size

Assignee

Synlogic Operating Company, Inc. · US

Inventors

Kristin Adolfsen · Medford, US
Per Greisen · Seattle, US
Isolde Callihan · South San Francisco, US
Adam Lawrence · Arlington, US
James Spoonamore · Emeryville, US
Jay H. Konieczka · Cambridge, US

Key dates

Filing date	Jun 3, 2022
Grant date	Sep 26, 2023
Priority date	—
Expiry date	Jun 3, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/19
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.